Literature DB >> 35286684

Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes.

Dominic P Byrne1, Mitchell H Omar2, Eileen J Kennedy3, Patrick A Eyers4, John D Scott5.   

Abstract

Generation of the prototypic second messenger cAMP instigates numerous signaling events. A major intracellular target of cAMP is Protein kinase A (PKA), a Ser/Thr protein kinase. Where and when this enzyme is activated inside the cell has profound implications on the functional impact of PKA. It is now well established that PKA signaling is focused locally into subcellular signaling "islands" or "signalosomes." The A-Kinase Anchoring Proteins (AKAPs) play a critical role in this process by dictating spatial and temporal aspects of PKA action. Genetically encoded biosensors, small molecule and peptide-based disruptors of PKA signaling are valuable tools for rigorous investigation of local PKA action at the biochemical level. This chapter focuses on approaches to evaluate PKA signaling islands, including a simple assay for monitoring the interaction of an AKAP with a tunable PKA holoenzyme. The latter approach evaluates the composition of PKA holoenzymes, in which regulatory subunits and catalytic subunits can be visualized in the presence of test compounds and small-molecule inhibitors.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AKAP; DSF; Kinase Inhibitor; Mass Spectrometry; Peptide; Protein kinase A (PKA); SDS-PAGE; cAMP

Mesh:

Substances:

Year:  2022        PMID: 35286684      PMCID: PMC9518671          DOI: 10.1007/978-1-0716-2245-2_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  84 in total

1.  A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes.

Authors:  M G Newlon; M Roy; D Morikis; D W Carr; R Westphal; J D Scott; P A Jennings
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Consequences of lysine 72 mutation on the phosphorylation and activation state of cAMP-dependent kinase.

Authors:  Ganesh H Iyer; Michael J Moore; Susan S Taylor
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

3.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase.

Authors:  J Reed; J S De Ropp; J Trewhella; D B Glass; W K Liddle; E M Bradbury; V Kinzel; D A Walsh
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

Review 5.  Swimming regulations for protein kinase A catalytic subunit.

Authors:  Matthew G Gold
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

Review 6.  Subcellular targeting of kinases and phosphatases by association with bifunctional anchoring proteins.

Authors:  V M Coghlan; Z E Hausken; J D Scott
Journal:  Biochem Soc Trans       Date:  1995-08       Impact factor: 5.407

7.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.

Authors:  T Chijiwa; A Mishima; M Hagiwara; M Sano; K Hayashi; T Inoue; K Naito; T Toshioka; H Hidaka
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

Review 8.  Cyclic nucleotide analogs as biochemical tools and prospective drugs.

Authors:  F Schwede; E Maronde; H Genieser; B Jastorff
Journal:  Pharmacol Ther       Date:  2000 Aug-Sep       Impact factor: 12.310

9.  Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling.

Authors:  Eirik A Torheim; Elisabeth Jarnaess; Birgitte Lygren; Kjetil Taskén
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

Review 10.  Creating order from chaos: cellular regulation by kinase anchoring.

Authors:  John D Scott; Carmen W Dessauer; Kjetil Taskén
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-08       Impact factor: 13.820

View more
  1 in total

1.  Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart.

Authors:  Feng Zhu; Qiushu Wang; Zhi Wang; Xu Zhang; Benkai Zhang; Hegui Wang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.